Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy‐Mee Yu, Benjamin R. Saville, Oghenekome Gbinigie et al.|The Lancet|2021Cited by 310
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trialChristopher Butler, Ly‐Mee Yu, Mona Bafadhel et al.|medRxiv|2021Cited by 28
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P. Blagden, Louise Brown, Ly‐Mee Yu et al.|British Journal of Cancer|2022Cited by 2